Interaction of Transcription Factors with Serum Response Factor
IDENTIFICATION OF THE Elk-1 BINDING SURFACE*

Yan LingDagger , Adam G. West, E. Claire Roberts, Jeremy H. Lakey, and Andrew D. Sharrocks§

From the Department of Biochemistry and Genetics, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, United Kingdom

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Serum response elements (SREs) play important roles in transforming extracellular signals into specific nuclear responses. The SRE-binding protein, serum response factor (SRF), plays a pivotal role in this process. Several transcription factors have been shown to interact with SRF and thereby create distinct complexes with different regulatory potentials. The ETS domain transcription factor Elk-1 is one such protein and serves to integrate distinct mitogen-activated protein kinase cascades at SREs. Elk-1 uses a short hydrophobic surface presented on the surface of an alpha -helix to interact with SRF. In this study we have used site-directed mutagenesis to identify residues in SRF that comprise the Elk-1 binding surface. The Elk-1 binding surface is composed of residues that lie on a hydrophobic surface-exposed groove located at the junction of the MADS box and C-terminal SAM motif. Different residues are implicated in interactions between SRF and the transcription factor Fli-1, indicating that although some overlap with the Elk-1 binding surface occurs, their interaction surfaces on SRF are distinct. Our data are consistent with the hypothesis that the SRF DNA-binding domain acts as docking site for multiple transcription factors that can bind to small surface-exposed patches within this domain.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The serum response element (SRE)1 within the c-fos promoter has been studied extensively and has developed into a paradigm for how immediate-early genes are regulated. The SRE is bound by the serum response factor (SRF) both in vitro and in vivo (reviewed in Refs. 1-3) and thus plays a pivotal role in regulating transcriptional activation of the c-fos promoter via this element. Multiple diverse extracellular signals are transduced through the SRE including both mitogenic stimuli (e.g. epidermal growth factor) and stress stimuli (e.g. UV light) (reviewed in Ref. 3). At least two alternative pathways exist to transduce these signals via SRF (4, 5). One pathway goes through a ternary complex composed of the SRE, SRF, and a member of the ternary complex factor (TCF) subfamily of ETS domain transcription factors (reviewed in Refs. 2 and 3). This pathway is responsive to the majority of mitogenic and stress stimuli. The second pathway acts via a TCF-independent mechanism and is responsive to alternative serum constituents such as lysophosphatidic acid and upstream activators such as the Rho family of GTPases (6, 7).

The TCF-dependent pathways have been extensively studied. In this complex, the TCF component is the recipient of signals transduced through the mitogen-activated protein kinase cascades (Refs. 8-13 and reviewed in Refs. 14 and 15). The TCFs use both protein-DNA (by their ETS domain) and protein-protein interactions to bind to the binary SRF·SRE complex (reviewed in Ref. 2) as predicted by the "grappling hook" model (1). A short region of the TCF Elk-1 (the B box) has been demonstrated to be sufficient for interaction with SRF (16). Upon binding to SRF, this region is thought to adopt an inducible alpha -helical structure in which hydrophobic amino acids play a major role (17). The minimum region of SRF required for this interaction with the TCFs in vitro maps to its minimal core DNA-binding domain (coreSRF) (18). Experiments using chimeric transcription factors have localized the TCF binding surface to the C-terminal half of this domain (18, 19). Moreover, the core domain is sufficient for correct dimerization, sequence-specific DNA binding, and protein-induced DNA bending by SRF (reviewed in Refs. 2 and 20). Recently the structure of this domain has been solved (21) and shown to adopt a novel fold in which the N-terminal portion (MADS box) makes all the DNA contacts. Dimerization is mediated by elements within the MADS box and additional contributions from the C-terminal extension (the SAM motif).

In addition to binding TCFs, the core DNA-binding domain of SRF is sufficient to form DNA complexes with or bind directly to other transcription factors including myogenic basic helix-loop-helix proteins (22), the ETS-domain protein Fli-1 (23, 24) and p65/NF-kappa B (25). Moreover, a higher order complex involving SRF, Phox, and TFII-I/SPIN and the c-fos SRE has also been identified (26). These diverse transcription factors show little homology with the Elk-1 B box, implying that they use alternative interaction motifs and different surfaces on SRF.

The aim of this study was to identify the TCF interaction surface on SRF. The recent elucidation of the structure of the minimal DNA-binding domain of SRF (21) permits both improved experimental design and interpretation of the biochemical data. By using an extensive mutagenic approach, we have identified a surface-exposed patch on SRF which is involved in interactions with Elk-1. The transcription factor Fli-1 interacts with a different surface on SRF which overlaps the Elk-1 binding region. Taken together our data are consistent with a model in which the SRF DNA-binding domain acts as a docking site with interaction surfaces for multiple transcription factors involved in diverse cellular processes.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Plasmid Constructs-- The following plasmids were constructed for making proteins by in vitro transcription/translation. pAS197 encodes the ETS DNA-binding domain and B box of Elk-1 (Elk1-168; amino acids 1-168) (17). pAS3052 encodes the N-terminally truncated zebrafish Fli-1 protein, Fli-219-451 (Fli-1 amino acids 219-451). pT3G-SRF encodes the DNA-binding domain of SRF (coreSRF; amino acids 132-222) (18).

pAS30 (Y195D), pAS31 (F197D) (28), pAS432 (V187A), pAS626 (S189A), pAS627 (E190A), pAS640 (H193A), pAS641 (T191A/H193A), pAS431 (V194A), pAS430 (T196A), pAS625 (V194A/T196A), pAS493 (T199A), pAS629 (R200A), pAS642 (T196A/R200A), pAS646 (Q203A/T207A), pAS429 (K201A), pAS643 (V194A/K201A), pAS494 (L202A), pAS630 (Q203A), pAS428 (P204A), pAS427 (I206A), pAS495 (T207A), pAS644 (T196A/T207A), pAS635 (V194E), pAS491 (T196E), pAS492 (T196K), pAS628 (A198D), pAS632 (T199D), pAS637 (Q203E), pAS636 (I206D), pAS631 (T207D), pAS634 (T210D), and pAS633 (Q216E) encode mutant derivatives of coreSRF from pT3G-SRF with the indicated site-directed mutations. pAS433, pAS434, pAS435, pAS439, and pAS52 encode point mutant derivatives of METcoreSRF from pAS37 (29) with site-directed mutations L155A, L155E, Y158A, T166A, and K154E/V144K, respectively. Mutations were introduced by a two-step PCR protocol using a mutagenic primer and two flanking primers as described previously (30). pAS489 encodes Elk-1-168 with the mutation L158P and was also constructed using this two-step PCR protocol. Details of mutagenic primers can be supplied upon request.

The following plasmids were used for protein expression in Escherichia coli. pAS77 encodes the GST-B box fusion (Elk-1 amino acids 139-168) (16). pAS58 encodes GSTcoreSRF (SRF amino acids 132-222) (16). Plasmids encoding the mutant GSTcoreSRF proteins E190A (pAS647), H193A (pAS656), T196A (pAS660), V194E (pAS650), Y195D (pAS651), T196K (pAS652), and Q203E (pAS653) were constructed by replacement of the EcoRI fragment in pAS58 with a PCR product (COR3 C-terminal primer; Ref. 16) derived from the corresponding pBluescript-based plasmids described above.

pAS76 contains the c-fos SRE cloned into the circular permutation vector pBEND2 (20).

Protein Production-- In vitro transcription and translation of SRF, Elk-1, and Fli-1 derivatives were carried out with TNTTM-coupled reticulocyte lysate system (Promega) according to the manufacturer's recommendations. 35S-Labeled proteins were analyzed by electrophoresis through 0.1% SDS-12% polyacrylamide gel electrophoresis before visualization and quantification of bands representing intact proteins by phosphorimaging (Fuji BAS-1500 phosphorimager and TINA 2.08e software).

GST fusion proteins were purified from E. coli as described previously (16). The purity and concentration of protein samples were estimated by SDS-polyacrylamide gel electrophoresis.

Gel Retardation and GST Pull-down Assays-- Pull-down assays for protein-protein interactions with GST-B box and GSTcoreSRF derivatives were carried out essentially as described previously (16).

Gel retardation assays were performed in 12-µl reaction volumes as described previously (28). Assays were carried out on the c-fos SRE (oligonucleotides ADS134 and ADS135; top strand, 5'-CTAGCTTACACAGGATGTCCATATTAGGACATCTGCGTCAGCAGG-3') or the CECI site (oligonucleotides ADS341 and ADS342; top strand, 5'-CGCGTGAGCCGGAAATGTGATCAACTATTTATAGATA-3'). The CArG box SRF-binding sites are underlined, and the Elk-1-binding sites (ets motifs) are shown in bold. The CECI site (combined ets and CArG) consists of the S30 ets motif identified by site selection (31) and the N10 site (29). Elk-1 binds to the ets motif in this site with higher affinity than to the c-fos SRE (31). Protein-DNA complexes were resolved by electrophoresis through nondenaturing 5% polyacrylamide (30% acrylamide, 0.8% bisacrylamide) gels cast in either 0.5× Tris/borate/EDTA (TBE) or 1× TBE for circular permutation assays. Relative DNA binding affinities were calculated by phosphorimager analysis of protein-DNA complexes (Fuji BAS1500; TINA 2.08e software). Experiments were carried out to achieve <= 50% of total DNA binding in protein-DNA complexes. Under these conditions, relative binding affinities within an experiment can be calculated by direct quantification of DNA-protein complexes. The scoring of these relative binding affinities is indicated in the legend to Table I.

Circular Permutation Analysis-- For circular permutation analysis, DNA fragments were produced by appropriate restriction enzyme digestion of PCR products derived from pAS76 (containing the SRE) and purified as described previously (20, 32). Curve fitting and apparent DNA bend angles were calculated as described previously (32). Bend angles are quoted as the average of three independent experiments. Standard deviations (n - 1) of bend angles are in the range 0.5-1.6°. To show direct visual comparisons of data obtained from proteins that give rise to complexes of differing mobilities, the data were normalized for the fastest mobility complex (µM) (32).

All figures were generated electronically from scanned images of autoradiographic images using Picture Publisher (Micrografx) and Powerpoint (Microsoft) software. Final images are representative of the original autoradiographic images.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Experimental Rationale-- A mutagenic approach was used to identify residues in SRF that are involved in binding Elk-1. Amino acids were either changed to alanines (removing potential interacting side chains) or to charged residues. The latter approach relies on introducing amino acids that will disrupt protein-protein contacts and therefore the residues need not be in direct contact with Elk-1 but might instead be in very close proximity to residues comprising the binding surface. Both these approaches have been used successfully in independent studies with virtually identical results to map surface residues on TATA binding protein which bind to components of the transcription preinitiation complex (33, 34). The majority of the mutations introduced were at single amino acid residues. Individual residues in the core DNA-binding domain of SRF could have multiple roles in addition to protein-protein interactions including DNA binding, dimerization, or protein-induced DNA bending. A combination of assays were therefore used to assess the function of mutant proteins in both the presence and absence of DNA.

Mutations were introduced into the minimal DNA-binding domain of SRF (coreSRF) and tested for binding to the truncated Elk-1 protein (Elk-1-168) which contains the ETS DNA-binding domain and the B box SRF-binding motif. These truncated proteins are sufficient for complex formation in both the presence and absence of DNA (16, 17). The results of these assays are presented below and summarized in Table I.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of the effect of amino acid substitutions in SRF on its interactions with Elk-1 and Fli-1
Results are presented relative to the wild-type protein (taken as 100%). The following ranges are indicated by the symbols: ++++, 80-100%; +++, 50-80%; ++, 20-50%; +, 5-20%; +/-, 1-5%, and -, <1%. All results are presented as averages of between two and seven independent experiments. Asterisks represent interactions that were enhanced relative to the wild-type protein. Shaded boxes represent significant decreases in the interaction of the mutant protein, see text for details.

DNA Binding by SRF Mutants-- Initially the mutant SRF proteins were tested for their ability to bind to the CArG (CC{A + T rich}6GG) box in the c-fos SRE. The majority of the mutant proteins bound the SRE with similar efficiency to the wild-type protein (Fig. 1; Table I). However, the mutants V194A/T196A, T199A, L202A, and T199D exhibited a reduced affinity for the SRE (Fig. 1, lanes 8, 9, 14, and 27). Binding of the mutants P204A, F197D, A198D, and I206D was severely reduced and not detectable by this assay (Fig. 1, lanes 16, 25, 26, and 29).


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 1.   DNA binding by SRF mutant proteins. Gel retardation analysis of binary complex formation between wild-type and mutant coreSRF proteins and the c-fos SRE. Equal molar quantities of each mutant protein (indicated above each lane) were used in the binding reactions. The locations of the free SRE and binary (2°) SRF·SRE complexes are indicated.

Ternary Complex Formation with Elk-1 and CArG Boxes-- The ability of the mutant SRF proteins to form ternary DNA-bound complexes with Elk-1 and the c-fos SRE was tested by gel retardation analysis. Protein-protein interactions with SRF are essential for efficient recruitment of Elk-1 into ternary complexes on this site (16). Assays were carried out using concentrations of SRF that give equal amounts of binary SRF·SRE complex. The efficiency of ternary complex formation was virtually identical for all the mutant SRF proteins tested (Fig. 2B) with the exception of the mutants V194E, T196E, and T196K which exhibited a reduced efficiency of complex formation (Fig. 2B, lanes 19, 21 and 22). In the case of V194E no ternary complex was detectable.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   Ternary complex formation by SRF mutant proteins and the c-fos SRE. A, diagrammatic representation of the ternary SRF·Elk-1·SRE complex. The c-fos SRE consists of a strong SRF-binding site (CArG box) and a weak Elk-1-binding site (ets motif). Elk-1 (open circles) is recruited to this site by protein-protein interaction between the B box and SRF (shaded circles) thereby supplementing interactions between the Elk-1 ETS domain and the ets motif. B, gel retardation analysis of ternary complex formation between wild-type and mutant coreSRF proteins, Elk-1-168 and the c-fos SRE. The amount of each mutant protein used (indicated above each lane) was adjusted to give equal amounts of binary SRF·SRE complex. Equal molar quantities of Elk-1-168 were added to each reaction. The locations of the free SRE, binary (2°) SRF·SRE and ternary (3°) SRF·Elk-1·SRE complexes are indicated.

To detect further mutations that affect ternary complex formation, we used a second assay system in which a high affinity ets motif is juxtaposed next to a weak CArG box in the CECI (combined ets and CArG) site (Fig. 3A). This arrangement of sites is the opposite that found in the c-fos SRE and allows recruitment of SRF by Elk-1.3 Under these conditions, protein-protein interactions are essential for the recruitment of SRF by Elk-1 into a ternary complex. In contrast to the results on the c-fos SRE, many of the mutant proteins exhibited a reduced efficiency of ternary complex formation on the CECI site (Fig. 3B; Table I). The mutant proteins E190A, T191A/H193A, V194A/T196A, T199A, Y195D, Q203E, T207D, and Q216E showed significant reductions in complex forming efficiency (<50% WT binding) (Fig. 3B, lanes 3-5, 8, 9, 22, 28, 30, and 32; Table I), whereas binding by the mutant proteins V194A/K201A, V194E, T196E, and T196K (Fig. 3B, lanes 13, 21, 23, and 24 and Table I) was barely detectable (<5% WT binding, not visible in Fig. 3B). No complex formation was observed by the mutants L202A, P204A, F197D, A198D, T199D, and I206D (Fig. 3B, lanes 14, 16, 25-27, and 29 and Table I). Moderate reductions (approx 60% WT binding) were also observed for the mutant proteins H193A, V194A, and I206A (Fig. 3B, lanes 4, 6 and 17 and Table I).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   Ternary complex formation by SRF mutant proteins at the CECI site. A, diagrammatic representation of the ternary SRF·Elk-1·CECI complex. The CECI site consists of a weak SRF-binding site (CArG box) and a strong Elk-1-binding site (ets motif). Elk-1 (open circles) recruits SRF to this site by protein-protein interactions between the B box and SRF (shaded circles). B, representative data from gel retardation analysis of ternary complex formation between wild-type and mutant coreSRF proteins and the CECI site. Equal molar quantities of Elk-1-168 and each mutant protein (indicated above each lane) were added to each reaction. The locations of the free CECI site, binary (2°) Elk-1·CECI and ternary Elk-1·SRF·CECI complexes are indicated.

The lack of complex formation by the mutants P204A, F197D, A198D, and I206D is probably attributable to disruptions in their DNA binding capabilities (see Fig. 1; Table I). Similarly, the mutant proteins V194A/K201A, L202A, and T199D exhibit significantly reduced DNA binding activity (Fig. 1; Table I). In contrast, DNA binding by the mutant proteins V194E, T196E, and T196K is unimpaired, suggesting that the effect of these mutations is specifically to disrupt SRF-Elk-1 interactions. Likewise, the reductions in complex formation by the mutants E190A, H193A, T191A/H193A, V194A, V194A/T196A, T199A, I206A, Y195D, Q203E, and T207D are also likely to be attributable to losses in protein-protein interactions with Elk-1.

Taken together these assays suggest key roles for amino acids Val-194 and Thr-196 in complex formation with Elk-1. Furthermore, several additional residues, Glu-190, His-193, Thr-199, Tyr-195, Gln-203, Ile-206, and Thr-207, are identified as part of or close to the Elk-1 binding surface of SRF.

Protein-Protein Interactions between Elk-1 and SRF Mutant Proteins in the Absence of DNA-- Direct protein-protein interactions between SRF and Elk-1 were investigated using the GST pull-down assay. Although Elk-1 and SRF are usually found as DNA-bound complexes, complexes can be detected in vitro in the absence of DNA using this assay (16). First, SRF mutants were translated in vitro as 35S-labeled proteins and tested for binding to an immobilized protein consisting of GST fused to the Elk-1 B box (GST-B box) (16). Initially, a series of SRF derivatives with mutations in the N terminus of the MADS box were tested. However, none of the tested mutations reduces the binding of SRF to the B box (Table I; data not shown). Further SRF derivatives were tested that harbor mutations in the C-terminal end of the MADS box or within the SAM domain. Of the alanine substitution mutants, the single mutants E190A, T199A, and P204A (Fig. 4A lanes 3, 9, and 16; Fig. 4B) and the double mutants V194A/T196A, T196A/T207A, and Q203A/T207A (Fig. 4A lanes 8, 19, and 21; Fig. 4B) display large decreases in binding to GST-B box (<50% wild-type binding). The residues Val-194, Thr-196, and Gln-203 probably play the major roles in the reductions observed in the double alanine mutants as single mutations in these residues also cause reductions in SRF binding to GST-B box (Fig. 4A; lanes 6, 7, and 15; Fig. 4B). Furthermore, the mutant protein I206A shows a moderate reduction in binding the Elk-1 B box (Fig. 4B, lane 7; 51% WT). The lack of binding by the P204A mutant is probably due to a structural change in SRF (see "Discussion"). However, the residues Glu-190, Val-194, Thr-196, Thr-199, and Ile-206 are directly implicated in binding to Elk-1 which correlates well with their proposed role in ternary complex formation on the CECI site (Fig. 3).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   Interaction of mutant SRF proteins the Elk-1 B box. A, representative data of a GST pull-down assay of 35S-labeled mutant SRF proteins by fusions of GST with the Elk-1 B box (GST-B box). Equal molar quantities of each mutant SRF protein were used (indicated above each lane). B, quantification of the data from pull-down assays with GST-B box. Data and S.E. represent the average of at least three independent experiments.

Further residues are implicated in binding the Elk-1 B box from analysis of the mutants with charged residues substitutions. The mutants V194E, Y195D, T196E, T196K, F197D, A198D, and I206D exhibited large decreases in binding to GST-B box (Fig. 4A lanes 21-26 and 29; Fig. 4B). Of these mutants, the structures of F197D, A198D, and I206D are probably severely perturbed (see "Discussion"). However, clear correlations are apparent with the effect of the mutations V194E, T196E, and T196K on complex formation by SRF on the CECI site (Fig. 3; Table I). Moderate reductions in binding to GST-B box could also be observed for Q203E and T207D (Fig. 4A lanes 28 and 30; Fig. 4B) which also correlates with reductions in their ability to recruit SRF to the CECI site (Fig. 3; Table I).

In summary, direct protein-protein interaction assays and DNA-bound ternary complex formation assays both suggest important roles for Glu-190, Val-194, Thr-196, Thr-199, and Ile-206 in forming the interaction surface with Elk-1.

To confirm that the differential interactions observed with the mutant SRF proteins and the isolated Elk-1 B box could be reproduced in its natural context, the interaction assay was repeated with reciprocal constructs in which a selection of the SRF mutants were fused to GST and the truncated Elk-1-168 protein was translated and labeled in vitro. As a control to assess levels of nonspecific binding, the mutant Elk-1 derivative Elk-1-168 (L158P) which is unable to bind to SRF (13) was used. Under these conditions, stronger interactions between SRF and Elk-1 are seen than to the isolated B box (Ref. 16 and data not shown).4

In comparison to the wild-type protein, the SRF mutants tested exhibited different levels of binding to Elk-1 (Fig. 5, A and B; Table I). Moreover, consistent with the reciprocal experiment (Fig. 4), the SRF mutant V194E showed the greatest decrease in binding (Fig. 5A, lanes 11 and 12). The mutant T196K also exhibited a significant decrease (Fig. 5A, lanes 15 and 16), and binding by the mutant E190A was also reduced to less than 50% (Fig. 5A, lanes 5 and 6). The other tested SRF mutants all bound to at least 50% of the level exhibited by the wild-type protein.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   Interaction of Elk-1 with mutant GST-SRF fusion proteins. A, GST pull-down assay of mutant SRF proteins fused to GST and 35S-labeled wild-type Elk-1-168 (W) or Elk-1-168 (L158P) (M). Equal molar quantities of each GST-SRF fusion protein were used (indicated above each pair of lanes). 33% of the labeled input proteins is loaded on the gel. B, quantification of the data from pull-down assays with GST-SRF. Data and S.E. represent the average of three independent experiments.

Taken together, our results demonstrate that in the absence of DNA, the mutations V194E, T196K, and T196E in SRF cause the greatest decrease in protein-protein interactions with Elk-1. These residues are therefore directly implicated in Elk-1 binding. The mutation of additional residues also causes reductions in direct SRF-Elk-1 interactions, implicating multiple amino acids in forming the SRF-Elk-1 interface.

Protein-induced DNA Bending Is Unaltered in SRF Mutant Proteins-- SRF-mediated DNA bending is observed in the ternary SRF·Elk-1·SRE complex (20). The magnitude of protein-induced DNA bending may affect the ability of SRF to recruit Elk-1 into ternary complexes. Several residues in SRF have been implicated in protein-induced DNA bending (32), including His-193 which is located in the vicinity of several residues investigated in this study (Fig. 8; see Ref. 21). To rule out an effect of the important residues identified in this study on protein-induced bending and hence ternary complex formation, the DNA-bending properties of several mutant proteins were investigated using the circular permutation assay. In this assay, changes in the mobility of protein-DNA complexes as the binding site location is moved with respect to DNA ends is indicative of protein-induced DNA bending. Moreover, this assay has the added advantage in that gross changes in protein structure would also become apparent.

Wild-type SRF induces an apparent DNA bend of 72° (Fig. 6A; 32). Similarly, the SRF mutants V194A/T196A, V194E, and T196E induce apparent DNA bends of comparable magnitude (68°-70°; Fig. 6, B-D). These mutant proteins also bind DNA with a similar efficiency to wild-type SRF (Fig. 1). Collectively, these results demonstrate that DNA binding by the SRF mutants V194A/T196A, V194E, and T196E is unaltered and that the differences in ternary complex formation with Elk-1 (Figs. 2 and 3) and Fli-1 (see below) are attributable to changes in direct protein-protein interactions.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 6.   DNA bending by mutant SRF proteins. Circular permutation analysis of wild-type (WT) and mutant SRF proteins (indicated above each panel) bound to the c-fos SRE. Probes were generated by digestion with MluI (lanes 1, 9, 17, and 25), BglII (lanes 2, 10, 18, and 26), XhoI (lanes 3, 11, 19, and 27), EcoRV (lanes 4, 12, 20, and 28), SmaI (lanes 5, 13, 21, and 29), StuI (lanes 6, 14, 22, and 30), RsaI (lanes 7, 15, 23, and 31), BamHI (lanes 8, 16, 24, and 32) (32). The data from each circular permutation experiment are shown graphically below each set of primary data. The relative mobilities of protein-DNA complexes were normalized for differences in complex mobilities (see "Materials and Methods") and plotted as a function of the position of the center of the SRE from the 5' end of the probe. Circular permutation data were fitted to a cosine function, and the relative bending angles calculated from these curves are indicated.

Complex Formation with the Transcription Factor Fli-1-- In addition to Elk-1, the core DNA-binding domain of SRF has also been demonstrated to form complexes with p65/NFkappa B (25) and Fli-1 (23, 24). The series of SRF mutant proteins were tested for interaction with these transcription factors to determine whether their interaction surfaces on SRF differ. First, interactions between p65/NFkappa B and the SRF mutant proteins were analyzed by the GST pull-down assay in which the DNA-binding domain of p65/NFkappa B was immobilized as a GST fusion protein. In contrast to the reductions in binding to the Elk-1 B box observed in several of the mutant SRF proteins (Fig. 4), no large decreases in binding to p65/NFkappa B were observed (data not shown). These results imply that different residues comprise the p65/NFkappa B and Elk-1 binding surfaces on SRF.

The ability of Fli-1 to form ternary complexes with SRF and the c-fos SRE was also investigated. In these assays, the quantity of each mutant SRF protein was adjusted to achieve equivalent amounts of binary SRF·SRE complex. An N-terminally truncated Fli-1 protein was used that requires the presence of SRF for recruitment into a ternary complex (Fig. 7A).5 All the mutant proteins could still form complexes with Fli-1 (Fig. 7; Table I) with the majority exhibiting comparable efficiency to the wild-type protein. However, the mutant proteins T199A, V194E, Y195D, and T196K exhibited reduced levels (approx 50%) of ternary complex formation (Fig. 7B, lanes 9, 19, 20, and 22). Conversely, significantly enhanced complex formation is observed in the mutant T196A and double mutants V194A/T196A, T196A/R200A, and T196A/T207A (Fig. 7B, lanes 7, 8, 11, and 17). The mutants that exhibited reduced binding to Fli-1 also exhibited reduced complex function with Elk-1 on the c-fos SRE and/or CECI site (Figs. 2 and 3), suggesting a common binding surface. However, the mutant protein V194E retains the ability to interact with Fli-1 while binding to Elk-1 is abolished. A further significant difference between interactions of Elk-1 and Fli-1 with SRF is the observation that the mutation T196A either alone or in combination with other mutations causes an enhancement of interaction of SRF with Fli-1 (approx 5-fold) while it reduces its interaction with Elk-1. Taken together, these data indicate that Fli-1 and Elk-1 use a similar interaction surface on SRF, but the residues within this surface have different roles in binding to each protein.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 7.   Ternary complex formation by SRF mutants with Fli-1 at the c-fos SRE. A, diagrammatic representation of the ternary SRF·Fli-1·SRE complex. A truncated Fli-1 construct (Fli-219-451) is recruited to this site by SRF (Y. Ling, A. G. West, E. C. Roberts, J. H. Lakey, and A. D. Sharrocks, unpublished data). Putative interactions between the sequences N-terminal to the ETS domain and SRF are indicated. B, gel retardation analysis of ternary complex formation between wild-type and mutant coreSRF proteins and the c-fos SRE. Equal molar quantities of Fli-219-451 and each mutant protein (indicated above each lane) were added to each reaction. The locations of the free SRE, binary (2°) SRF·SRE and ternary (3°) SRF·Fli-1·SRE complexes are indicated.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Protein-protein interactions play a key role in the formation of the ternary nucleoprotein which forms between SRF, Elk-1, and the c-fos SRE (Refs. 16, 18, and 19 and reviewed in Ref. 2). The interaction surface on Elk-1 is provided by residues in the conserved B box which is predicted to inducibly form an alpha -helix upon interaction with SRF (17). In this study we have used site-directed mutagenesis to identify residues which comprise the Elk-1 binding surface on SRF.

The Elk-1 Binding Surface-- Residues in SRF were mutated to either alanine or charged residues. A reduction of interaction upon introduction of an alanine residue was taken as evidence for a direct role of the amino acid in binding to Elk-1. Moderate effects by introduction of charged residues suggest that the residues are close to (but not necessarily part of) the Elk-1-binding motif, whereas severe effects indicate that the residues are probably within the binding surface. Based on these criteria, Glu-190, Val-194, Thr-196, Thr-199, and Ile-206 are identified as residues that are important in forming the binding surface, and Tyr-195, Gln-203, and Thr-207 are located close to the binding surface. Significantly, these residues form a continuous surface-exposed patch, whereas residues that are not thought to be part of this surface (including Thr-210, Gln-216, Val-187, Ser-189, Arg-200, and Lys-201) are located outside this patch (Fig. 8, B-D). Other residues such as Ile-206 whose mutation causes moderate changes in Elk-1 binding are located close to this patch (Fig. 8E). The total loss of Elk-1 binding exhibited by the mutant V194E is consistent with the central location of this residue in the binding surface (Fig. 8, C and D). This surface-exposed patch is predominantly hydrophobic in character (Fig. 8B) and is consistent with the observation that the residues in Elk-1 which play important roles in SRF binding are hydrophobic in character and are predicted to form a hydrophobic surface presented on the face of an alpha -helix (17). Together, our data are therefore consistent with a model in which protein-protein interactions between Elk-1 and SRF are mediated by the interaction of the hydrophobic surface of an alpha -helix formed by the Elk-1 B box and a hydrophobic patch on the surface of SRF. Recently, the structure of the related yeast MADS box protein Mcm1 in a ternary complex with DNA-bound MATalpha 2 has been solved (35). In this complex, a surface-exposed hydrophobic groove forms the binding surface for MATalpha 2. One end of this groove is centered on Val-69 with other defining residues including Phe-72 and Thr-74 toward the opposite end of the groove. The analogous residues in SRF (Val-194, Phe-197, and Thr-199) all lie within the Elk-1 binding surface (Fig. 8, B-D). Furthermore, MATalpha 2 inserts a phenylalanine residue into the hydrophobic pocket surrounding Val-69. As three aromatic residues in Elk-1 are critical for interaction with SRF (17), it is tempting to speculate that one of these residues occupies a similar position in the hydrophobic pocket surrounding Val-194 in SRF. This scenario is consistent with the severe reduction in Elk-1 binding caused by the introduction of a charged residue in place of Val-194.


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 8.   The Elk-1-binding surface on SRF. A, the locations of mutated residues in the primary amino acid sequence are indicated by green dots. Residues comprising secondary structural elements in SRF are bracketed. Amino acids that define the Elk-1-binding surface are indicated by red shaded boxes. B, van der Waals representation of the SRF core DNA-binding domain bound to DNA (21). The DNA is shown in green and hydrophobic and backbone atoms within the SRF residues are indicated in gray. Hydrophilic side chains are indicated in blue (nitrogen atoms) and red (oxygen atoms). A predominantly hydrophobic groove that contains the amino acids which constitute the Elk-1 binding surface is outlined in yellow, and the atoms within this groove are shown schematically in E. E, color coding of the residues is as in F and G; Ile-206 (I206) and other residues (single letter code is used) lying on the hydrophobic groove are shown in gray. C and D, location of mutated amino acids in the tertiary SRF-DNA structure. The DNA is shown in green, and the two SRF monomers are shown in white and yellow. Views perpendicular to (C) and along (D) the DNA axis are presented. Residues identified by mutagenesis which define the Elk-1 binding surface or are implicated in being close to the binding surface are shown in red and orange, respectively. Amino acids that are unimportant for interaction with Elk-1 are indicated in blue. Keys indicating the identity of the highlighted amino acids in C and D are given in F and G. The colors of the outlines of each amino acid are the same as in C and D.

A previous study has pinpointed residues Ala-198, Arg-200, and Gln-203 as determinants of the differential ability of SRF and the yeast MADS box protein ArgRI to bind to Elk-1 (18). Furthermore, an additional study has implicated residues spread over a wider area (Ser-189-Met-205) as contributing to their differential Elk-1 binding capabilities (19). Our results are consistent with both studies and implicate residues from within the beta I-beta II turn, beta II and beta II-alpha II turn in forming the Elk-1 binding surface (Fig. 8A). Together with the SRF structure (Ref. 21; Fig. 8, B-D), our results allow a molecular rationale to be applied to explain the results of these previous studies. The insertion of Ala-198 and Gln-203 into ArgRI is likely to result in the removal of inhibitory effects of the side chains of the analogous residues (Thr and Glu, respectively). The mutation Q203E inhibits interactions of SRF with Elk-1 (Table I), and the mutation A198T would likely introduce a bulky residue into the center of the Elk-1 binding surface on SRF (Fig. 8, B-D). The combination of these residues in ArgRI would therefore inhibit ternary complex formation.

The mutation of several residues that are predicted to lie within the binding surface, including F197D, A198D, and I206D, had deleterious effects on DNA binding in addition to interaction with Elk-1. Their role in protein-protein interactions could not therefore be unambiguously assessed. The effect of F197D has previously been attributed to disruption of the dimerization interface (21, 28). Similarly, the introduction of charged residues in place of Ala-198 and Ile-206 is likely to have severe structural consequences as these side chains are at least partially buried in the hydrophobic core of the protein (Fig. 8; Ref. 21). The mutation of Pro-204 is also likely to cause a structural change in the C terminus of the DNA-binding domain as this helps define the orientation of the turn between beta II and alpha II structural elements (21).

The mutant protein T191A/H193A exhibits markedly decreased binding in DNA-bound complexes on the CECI site but virtually wild-type binding in pull-down assays, thereby suggesting a role for these residues in DNA-dependent interactions. This SRF mutant exhibits reduced DNA bending properties in comparison to the wild-type protein,6 suggesting that DNA structure may play a role in ternary complex formation. We are currently exploring this possibility further.

Binding Surfaces for Other Transcription Factors-- Fli-1 (23, 24) and p65/NFkappa B (25) can both form complexes with SRF although in the former case, the biological significance is unknown. Testing of these transcription factors in addition to Elk-1 for binding to the panel of SRF mutants identified residues that appear to have different roles in binding each protein, e.g. Thr-199 (Elk-1) and Thr-196 (Fli-1). In contrast, other residues (e.g. Glu-190 and Val-194) play key roles in binding both Elk-1 and Fli-1. None of the mutations caused dramatic reductions (or enhancements) in interaction with p65/NFkappa B, indicating that the tested residues either play different roles or that different residues comprise the p65/NFkappa B binding surface. The observation that these proteins interact using different surfaces is consistent with the observation that neither Fli-1 nor p65/NFkappa B exhibits strong homology to the B box SRF interaction motif of Elk-1. Further studies are required to fully define the interaction epitopes of Fli-1 and p65/NFkappa B, but it is interesting to note that Val-194 appears to form an important part of each interaction surface and is associated within a hydrophobic cleft in the protein (Fig. 8E). Furthermore, removal of the side chain of the neighboring residue Thr-196 significantly enhances (5-10-fold; Fig. 7; Table I) the formation of complexes between Fli-1 and SRE-bound SRF. This mutation removes a hydrophilic side chain and increases the size of the hydrophobic groove on the surface of SRF (Fig. 8, B and E). One possible role for this residue may be to reduce potential interactions with Fli-1 in vivo. Further experiments are required to address the possible physiological significance of this observation.

In summary, we have defined a small surface-exposed patch on SRF that forms the binding interface with the Elk-1 B box. Furthermore, we have demonstrated that other transcription factors bind to different surfaces on SRF which in part appear to overlap the Elk-1 binding surface. The related yeast MADS box protein Mcm1 also binds to multiple co-regulatory proteins (reviewed in Ref. 27). One of these, MATalpha 2, binds to a surface-exposed hydrophobic groove which is located in an analogous position to the Elk-1 binding surface on SRF (35). Our data are consistent with the notion that MADS box proteins act as DNA-bound targets that allow the recruitment of many different transcription factors and hence allow different responses to diverse cellular signals.

    ACKNOWLEDGEMENTS

We thank Margaret Bell and Catherine Pyle for excellent technical and secretarial assistance and Bob Liddell for DNA sequencing and oligonucleotide synthesis. We are grateful to members of our laboratory for stimulating discussions and comments on the manuscript. We are grateful to Neil Perkins for reagents and Song Tan and Tim Richmond for communicating data prior to publication.

    FOOTNOTES

* This work was supported by the North of England Cancer Research Campaign and Medical Research Council Studentships (to A. G. W. and E. C. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Present address: Marie Curie Research Institute, The Chart, Oxted, Surrey, RH8 OTL, United Kingdom.

§ Research Fellow of the Lister Institute of Preventative Medicine. To whom correspondence should be addressed. Tel.: 0044-191 222 8800; Fax: 0044-191 222 7424; E-mail: a.d.sharrocks{at}ncl.ac.uk.

1 The abbreviations used are: SRE, serum response element; SRF, serum response factor; TCF, ternary complex factor; PCR, polymerase chain reaction; GST, glutathione S-transferase; SAM, SRF, ArgRI, Mcm1; MADS, Mcm1, ArgRI/AG, DEFA, SRF.

2 A. L. Brown, T. F. Schilling, A. Rodaway, T. Jowett, P. W. Ingham, R. Patient, and A. D. Sharrocks, submitted for publication.

3 E. C. Roberts, unpublished data.

4 Y. Ling and A. D. Sharrocks, unpublished data.

5 A. D. Sharrocks, unpublished data.

6 A. G. West and A. D. Sharrocks, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  1. Treisman, R. (1992) Trends Biochem. Sci. 17, 423-426[CrossRef][Medline] [Order article via Infotrieve]
  2. Treisman, R. (1995) EMBO J. 14, 4905-4913[Medline] [Order article via Infotrieve]
  3. Cahill, M. A., Janknecht, R., and Nordheim, A. (1996) Curr. Biol. 6, 16-19[Medline] [Order article via Infotrieve]
  4. Hill, C. S., Wynne, J., and Treisman, R. (1994) EMBO J. 13, 5421-5432[Abstract]
  5. Johansen, F.-E., and Prywes, R. (1994) Mol. Cell. Biol. 14, 5920-5928[Abstract]
  6. Hill, C. S., Wynne, J., and Treisman, R. (1995) Cell 81, 1159-1170[Medline] [Order article via Infotrieve]
  7. Hill, C. S., and Treisman, R. (1995) EMBO J. 14, 5037-5047[Abstract]
  8. Price, M. A., Cruzalegui, F. H., and Treisman, R. (1996) EMBO J. 15, 6552-6563[Abstract]
  9. Whitmarsh, A. J., Shore, P., Sharrocks, A. D., and Davis, R. J. (1995) Science 269, 403-407[Medline] [Order article via Infotrieve]
  10. Whitmarsh, A. J., Yang, S.-H., Su, M. S.-S., Sharrocks, A. D., and Davis, R. J. (1997) Mol. Cell. Biol. 17, 2360-2371[Abstract]
  11. Strahl, T., Gille, H., and Shaw, P. E. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 11563-11568[Abstract/Free Full Text]
  12. Janknecht, R., and Hunter, T. (1997) EMBO J. 16, 1620-1627[Abstract/Free Full Text]
  13. Cavigelli, M., Dolfi, F., Claret, F. X., and Karin, M. (1995) EMBO J. 14, 5957-5964[Abstract]
  14. Treisman, R. (1996) Curr. Opin. Cell Biol. 8, 205-215[CrossRef][Medline] [Order article via Infotrieve]
  15. Whitmarsh, A. J., and Davis, R. J. (1996) J. Mol. Med. 74, 589-607[CrossRef][Medline] [Order article via Infotrieve]
  16. Shore, P., and Sharrocks, A. D. (1994) Mol. Cell. Biol. 14, 3283-3291[Abstract]
  17. Ling, Y., Lakey, J. H., Roberts, E. C., and Sharrocks, A. D. (1997) EMBO J. 16, 2431-2440[Abstract/Free Full Text]
  18. Mueller, C. G. F., and Nordheim, A. (1991) EMBO J. 10, 4219-4229[Abstract]
  19. Shaw, P. E. (1992) EMBO J. 11, 3011-3019[Abstract]
  20. Sharrocks, A. D., and Shore, P. (1995) Nucleic Acids Res. 23, 2442-2449[Abstract]
  21. Pellegrini, L., Tan, S., and Richmond, T. J. (1995) Nature 376, 490-498[CrossRef][Medline] [Order article via Infotrieve]
  22. Groisman, R., Masutani, H., Leibovitch, M.-P., Robin, P., Soudant, I., Trouche, D., and Harel-Bellan, A. (1996) J. Biol. Chem. 271, 5258-5264[Abstract/Free Full Text]
  23. Watson, D. K., Robinson, L., Hodge, D. R., Kola, I., Papas, T. S., and Seth, A. (1997) Oncogene 14, 213-221[CrossRef][Medline] [Order article via Infotrieve]
  24. Magnaghi-Jaulin, L., Masutani, H., Robin, P., Lipinski, M., and Harel-Bellan, A. (1996) Nucleic Acids Res. 24, 1052-1058[Abstract/Free Full Text]
  25. Franzoso, G., Carlson, L., Brown, K., Daucher, M. B., Bressler, P., and Siebenlist, U. (1996) EMBO J. 15, 3403-3412[Abstract]
  26. Grueneberg, D. A., Henry, R. W., Braver, A., Novina, C. D., Cheriyath, V., Roy, A. L., and Gilman, M. (1997) Genes Dev. 11, 2482-2493[Abstract/Free Full Text]
  27. Shore, P., and Sharrocks, A. D. (1995) Eur. J. Biochem. 229, 1-13[Abstract]
  28. Sharrocks, A. D., Gille, H., and Shaw, P. E. (1993) Mol. Cell. Biol. 13, 123-132[Abstract]
  29. Sharrocks, A. D., Von Hesler, F., and Shaw, P. E. (1993) Nucleic Acids Res. 21, 215-221[Abstract]
  30. Shore, P., Whitmarsh, A. J., Bhaskaran, R., Davis, R. J., Waltho, J. P., and Sharrocks, A. D. (1996) Mol. Cell. Biol. 16, 3338-3349[Abstract]
  31. Shore, P., and Sharrocks, A. D. (1995) Nucleic Acids Res. 23, 4698-4706[Abstract]
  32. West, A. G., Shore, P., and Sharrocks, A. D. (1997) Mol. Cell. Biol. 17, 2876-2887[Abstract]
  33. Bryant, G. O., Martel, L. S., Burley, S. K., and Berk, A. J. (1996) Genes Dev. 10, 2491-2504[Abstract]
  34. Tang, H., Sun, X., Reinberg, D., and Ebright, R. H. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1119-1124[Abstract/Free Full Text]
  35. Tan, S., and Richmond, T. (1998) Nature 391, 660-666[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.